Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Drug Delivery and Translational Research|November 30, 2017
Therapeutic prospects of microRNAs in cancer treatment through nanotechnologyRajendra Awasthi, Michael John Rathbone, Philip Michael Hansbro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 18, 2018
Functional relevance of SATB1 in immune regulation and tumorigenesisKrishna P Sunkara, Gaurav Gupta, Philip M Hansbro, et al.
Oncology Reports|April 8, 2004
Effect of short-term morphine exposure on P-glycoprotein expression and activity in cancer cell linesMarina Pajic, Mary Bebawy, Janelle M Hoskins, et al.
Drug Development and Industrial Pharmacy|April 9, 2010
Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell modelMehra Haghi, Paul M Young, Daniela Traini, et al.
Plos One|April 18, 2013
Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cellsRitu Jaiswal, Frederick Luk, Penelope V Dalla, et al.
Pharmacological Research|July 14, 2010
Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cellsBhavani Prasad Kota, Van H Tran, John Allen, et al.
Neoplasia (New York, N.Y.)|January 26, 2016
Isolation of Human CD138(+) Microparticles from the Plasma of Patients with Multiple MyelomaSabna Rajeev Krishnan, Frederick Luk, Ross D Brown, et al.
Current Drug Targets|March 27, 2018
Nanoparticles in Cancer Treatment: Opportunities and ObstaclesRajendra Awasthi, Ariane Roseblade, Philip Michael Hansbro, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 21, 2013
Cell-derived microparticles: new targets in the therapeutic management of diseaseAriane Roseblade, Frederick Luk, Tristan Rawling, et al.
Pageof 7